Fortrea Holdings Inc. (NasdaqGS: FTRE)
Health Care · Life Sciences Tools & Services · US
$20.92
+0.38% today · +93.9% 1Y
Fortrea Holdings Inc. (NasdaqGS: FTRE) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.98B and employs 14,000 people.
Over the last twelve months the share price has gained 93.9%, trading between 8.55 and 23.51.
Tweenvest scores Fortrea Holdings Inc. across four factors: quality 54/100, value 49/100, growth 7/100. Its strongest factor is quality.
FTRE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.98B
- Revenue (TTM)
- $2.68B
- P/E
- —
- EPS
- -0.92
- Dividend yield
- —
- Beta (5Y)
- 1.91
- 52-week high
- $23.51
- 52-week low
- $8.55
- Avg volume (3M)
- —
- Shares outstanding
- 95.10M
- Employees
- 14,000
- Next earnings
- —
About Fortrea Holdings Inc.
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
- ISIN
- US34965K1079
- Founded
- 2023
- Listed since
- Jun 20, 2023
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai InnoStar Bio-tech Co., Ltd.SHSE: 688710 | $2.10B | CN¥99.80 | -5.13% |
| AddLife AB (publ)OM: ALIF B | $2.06B | Skr169.00 | +1.14% |
| Shanghai Medicilon Inc.SHSE: 688202 | $2.04B | CN¥104.00 | -1.73% |
| LigaChem Biosciences Inc.KOSDAQ: A141080 | $2.01B | ₩73,300.00 | -10.94% |
| SKAN Group AGSWX: SKAN | $1.91B | CHF70.50 | -0.28% |
| Suzhou Sepax Technologies Co., Ltd.SHSE: 688758 | $1.81B | CN¥29.06 | -3.55% |
| PolyPeptide Group AGSWX: PPGN | $1.74B | CHF43.95 | +0.23% |
| OneSource Specialty Pharma LimitedNSEI: ONESOURCE | $1.73B | Rs1,461.30 | -3.10% |
Figures last refreshed Oct 11, 2026.